A Safety Trial to Evaluate an Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides Difficile

NCT07649096 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

56

Enrollment

NIH

Sponsor class

Conditions

Clostridium Difficile Infection

Interventions

BIOLOGICAL: FZ002
OTHER: Placebo for FZ002

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]